Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
World Journal of Gastroenterology|February 28, 2014
What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?Ian C LawranceExpert Opinion on Investigational Drugs|February 27, 2015
Early investigational TNF receptor antagonists for the treatment of ulcerative colitisIan C LawranceWorld Journal of Gastroenterology|August 12, 2014
Preventing infective complications in inflammatory bowel diseaseJustine Mill, Ian C LawranceJournal of Gastroenterology and Hepatology|February 18, 2009
Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical settingMatthew W Trinder, Ian C LawranceJournal of Gastroenterology and Hepatology|September 12, 2007
Careful patient selection may improve response rates to infliximab in inflammatory bowel diseaseCallum B Pearce, Ian C LawranceExpert Review of Gastroenterology & Hepatology|May 6, 2017
Dysplasia and colorectal cancer surveillance in inflammatory bowel diseaseSamba Siva Reddy Pulusu, Ian C LawranceDigestive Diseases and Sciences|January 30, 2015
Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast functionAngela C Baird, Frances Lloyd, Ian C LawranceExpert Review of Gastroenterology & Hepatology|October 29, 2019
Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiomeSimon Ghaly, Prue H Hart, Ian C LawranceInflammatory Bowel Diseases|February 11, 2011
Predictors of fibrostenotic Crohn's diseaseFlorian Rieder, Ian C Lawrance, Andre Leite, et al.Inflammatory Bowel Diseases|April 26, 2013
Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic eraLena W Y Thin, Kevin Murray, Ian C LawrancePageof 7